Article

Molecular basis for cross-activation of NPFF2R by a short PrRP-related peptide

Xin Li1,2, Shuai Li1, Hong Shan1, Qing-ning Yuan3, Xin-heng He4, Qian He1,2, Min Zhang1,2, Yang Li1,5, Wen Hu1, Kai Wu1, H. Eric Xu1,2,3, Li-hua Zhao3
1 State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China
2 University of Chinese Academy of Sciences, Beijing 100049, China
3 State Key Laboratory of Medical Genomics, Research Center for Medicinal Structural Biology, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200025, Chin
4 Lingang Laboratory, Shanghai 201100, China
5 chool of Pharmacy, Fudan University, Shanghai 201203, China
Correspondence to: H. Eric Xu: eric.xu@simm.ac.cn, Li-hua Zhao: zlh13131@rjh.com.cn,
DOI: 10.1038/s41401-025-01741-1
Received: 14 July 2025
Accepted: 17 December 2025
Advance online: 4 February 2026

Abstract

Prolactin-releasing peptide (PrRP) is an endogenous ligand for the PrRPR, whose activation has been linked to anti-obesity effects. However, PrRP and its analogs also activate the neuropeptide FF receptor 2 (NPFF2R), which is associated with adverse cardiovascular effects. Understanding how PrRP-related peptides differentially engage these two distinct receptors is critical for developing safer, more selective therapeutics. In this study, we present cryo-EM structures of the PrRP analog GUB08248 bound to PrRPR-Gαq and NPFF2R-Gαi at resolutions of 2.45 Å and 2.85 Å, respectively. These structures reveal a conserved ligand recognition mode across both receptors, while highlighting distinct receptor-specific interactions. The NPFF2R-Gαi complex further uncovers key features of receptor activation and G protein coupling. Together, our results offer structural insights that could guide structure-based drug design strategies favoring PrRPR selectivity, thereby advancing the therapeutic potential of the PrRP-PrRPR axis for obesity treatment.

Keywords: prolactin-releasing peptide; PrRPR; NPFF2R; ligand recognition; obesity therapy

Article Options

Download Citation

Cited times in Scopus